Good idea or not, institutional investors research comments about companies on twitter as part of the investing criteria. The lack of social media, especially twitter and linkedin.com usage by employees and C-level of Mimedx creates a massive vacuum that is happily filled by the people that live to criticize this company. MiMedx should hire an actual digital agency today that can use social media as a positive - as for now and the immediate future - social media regarding Mimedx will be dominated by the liars and shorts that seek to sow innuendo and fear to those institutional investors. Clearly some of these people are hoping to make money from shorting the stock, some from being long on Mimedx competitors or perhaps both. I am sure Mimedx competition loves the constant drumbeat of negativity regarding this company across the internet. The company stock price lifting will create more capital to pay higher salaries and commissions and increase the overall impression of the SUCCESS of the company and then ultimately its products - artificial stock depression through shorting and social media bashing is a factor in the ability to SELL these products. Would people buy Tesla cars if there was nothing but bad social media content about the stock and the company? The new CEO seems to be ignorant of the importance of social media - that will ultimately need to be dealt with either with a NEW CEO or perhaps he will get his head out of his ass and stop pretending it is 1980 and the internet doesn't exist. They hire an investor relations manager but not a social media manager. What a mistake. Social media IS the new investor relations function. Look forward to the first multimillion dollar lawsuit for slander/ liability brought against these social media keyboard warriors for falsely claiming these products don't work or calling Mimedx a fraud, if the CEO has the balls to do it. The social media liars and shorts are the ones that should be facing jail time along with former CEO. At least people are now calling them out by NAME they can't hide anymore. Good luck to all.
Liars, shorts, slander... blah blah blah. Bill? Pete? Yancy? You mad bros? BTW, it’s pretty obvious that you don’t know much about anything because (since you brought it up) the truth is an absolute defense. And you should brush up on Anti-SLAPP laws, bro.
Interesting. Am I hearing legal action is being prepared against certain vocal social media accountholders that are publicly ridiculing trial data ?
By trial data do you mean the data by Mimedx employees that doesn’t hold water and isn’t considered to be credible in the medical community because of conflict of interest? Or the bought and paid for data by Mimedx consultants paid astronomical amounts of money (also a conflict of interest) and/or product and also considered not to be credible? When they publish and are in approved in JAMA or The Lancet, then and only then will they be considered credible.
Is coming to CP to pump the stock and obsess over people you don’t know behaving like business people? Your big dick energy isn’t working here.
Tick Tok, the FDA is coming: “We are now reaffirming the timing of the end of the compliance and enforcement discretion policy for certain human cell, tissue, and cellular and tissue-based products (HCT/Ps), including regenerative medicine therapies. The period during which the FDA intends to exercise enforcement discretion with respect to the IND and premarket approval requirements for certain HCT/Ps ends on May 31, 2021, and will not be extended further.”
